What is the recommended dosing regimen, contraindications, and alternative therapy for Talicia (omeprazole 20 mg, amoxicillin 500 mg, clarithromycin 500 mg) in a patient who can swallow tablets and has no known allergy to penicillins or macrolides?

Talicia Dosing and Clinical Guidance

Talicia should be dosed as 4 capsules three times daily (morning, mid-day, evening) with at least 4 hours between doses, taken with food for 14 days, delivering rifabutin 50 mg, amoxicillin 1,000 mg, and omeprazole 40 mg per dose. 1

Dosing Regimen

Administration specifics:

• Take 4 capsules three times daily with food
• Maintain at least 4 hours between doses
• Swallow capsules whole with a full glass of water (8 ounces)
• Do NOT crush or chew capsules
• Do NOT take with alcohol
• Duration: 14 days 1

Missed dose management:

• If next dose is >4 hours away: take missed dose immediately
• If next dose is within 4 hours: take missed dose immediately but delay next dose to maintain 4-hour spacing 1

Contraindications

Talicia is absolutely contraindicated in patients with:

1. Hypersensitivity to any component:

   • β-lactam antibiotics (penicillins, cephalosporins)
   • Benzimidazoles (PPIs)
   • Rifamycins
   • Any other component of Talicia 1

2. Drug interactions:

   • Rilpivirine-containing products (PPI component contraindicated)
   • Delavirdine (rifabutin component contraindicated)
   • Voriconazole (rifabutin component contraindicated) 1

Critical warning: Patients with penicillin allergy history may experience severe cross-reactions with cephalosporins. Always obtain detailed allergy history before prescribing 1.

Alternative Therapies

Since your patient can swallow tablets and has no penicillin or macrolide allergies, Talicia is appropriate. However, if Talicia fails or is contraindicated, consider these alternatives based on current guidelines:

First-Line Alternatives (if Talicia not used initially):

Concomitant quadruple therapy (PAMC):

• PPI (omeprazole 20 mg) + amoxicillin 1,000 mg + metronidazole 500 mg + clarithromycin 500 mg, all twice daily for 14 days
• Recommended by all major guidelines 2

Bismuth quadruple therapy (PBMT):

• PPI + bismuth (~300 mg four times daily) + metronidazole 500 mg three-four times daily + tetracycline 500 mg four times daily for 14 days
• Recommended by all major guidelines 2

After Talicia Failure:

If Talicia (rifabutin-based) fails, avoid re-using rifabutin. The guidelines recommend:

1. Bismuth quadruple therapy if not previously used 3, 2
2. Levofloxacin triple therapy: PPI + amoxicillin 1,000 mg twice daily + levofloxacin 500 mg once daily for 14 days (only if levofloxacin resistance is low in your area) 2
3. High-dose dual therapy: High-dose PPI (e.g., rabeprazole 20 mg four times daily) + amoxicillin 750 mg four times daily for 14 days 3, 2

Critical principle: After two failed therapies with confirmed adherence, obtain H. pylori susceptibility testing to guide subsequent regimens 3. Never re-use clarithromycin or levofloxacin after failure due to rapid resistance development 2.

Clinical Context

Talicia (RHB-105) represents a rifabutin-based regimen that achieved 89.4% eradication in the ERADICATE Hp trial, significantly outperforming standard-of-care (63%) 4. This makes it a viable rescue therapy option, particularly as rifabutin resistance remains rare 3.

Common adverse effects include diarrhea (12.7%), headache (11.9%), chromaturia (9.3%), and abdominal tenderness (6.8%) 4. These are generally mild and well-tolerated.

Key pitfall: Ensure patients understand the importance of taking all doses with food and avoiding alcohol, as these factors affect absorption and tolerability 1.